Welcome to Grant for Multiple Sclerosis Innovation (GMSI)

GMSI

Grant for Multiple Sclerosis Innovation

The four award winners of the first Grant for Multiple Sclerosis Innovation (GMSI) were announced during the satellite symposium at the 29th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, on Saturday 5 October 2013. The opening of the second GMSI was also announced during this symposium.

Applications for the 2014 GMSI award are now closed. The awards will be announced during the ECTRIMS 2014 congress, 10-12 September, Boston, USA.

Should you wish to apply for the 2015 grant, applications will re-open after ECTRIMS 2014.

The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.